Marshall Wace’s Forbion European Acquisition Corp. Class A Ordinary Shares FRBN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-209,655
Closed -$2.25M 2827
2023
Q2
$2.25M Sell
209,655
-378,954
-64% -$4.02M ﹤0.01% 1346
2023
Q1
$6.2M Hold
588,609
0.01% 893
2022
Q4
$6.09M Hold
588,609
0.01% 1065
2022
Q3
$5.95M Hold
588,609
0.01% 1250
2022
Q2
$5.89M Hold
588,609
0.01% 1227
2022
Q1
$5.87M Buy
+588,609
New +$5.84M 0.01% 1250

Other funds holding FRBN

Marshall Wace's FRBN Position: Q3 2023 in Review

Marshall Wace sold out of Forbion European Acquisition Corp. Class A Ordinary Shares (FRBN) in Q3 2023, closing a stake of 209,655 shares — an estimated $2.25M sold.

Marshall Wace first reported a position in FRBN in Q1 2022 and held it in 6 quarters. The position peaked at $6.2M in Q1 2023. 33 funds tracked by Wall St. Rank hold FRBN as of Q3 2023.

  • Marshall Wace reported no remaining Forbion European Acquisition Corp. Class A Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Marshall Wace sold 209,655 Forbion European Acquisition Corp. Class A Ordinary Shares shares in Q3 2023, an estimated $2.25M.
  • Marshall Wace first reported a position in Forbion European Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 6 quarters.
  • Marshall Wace's Forbion European Acquisition Corp. Class A Ordinary Shares position peaked at $6.2M in Q1 2023.
  • 33 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Class A Ordinary Shares as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.